K. P. van Rhee

Patients with Obesity Should be Recognised as a Special Patient Population During Drug Development of Antibacterial and Antifungal Agents; A Call to Action

C. Knibbe, K. P. van Rhee, P. D. van der Linden, 2024, Clinical pharmacokinetics.

Impact of mucositis on oral bioavailability and systemic exposure of ciprofloxacin Gram-negative infection prophylaxis in patients with haematological malignancies

S. Geerlings, R. V. van Hest, P. D. van der Linden, 2022, The Journal of antimicrobial chemotherapy.

Ciprofloxacin Pharmacokinetics After Oral and Intravenous Administration in (Morbidly) Obese and Non-obese Individuals: A Prospective Clinical Study

P. D. van der Linden, C. Knibbe, E. Krekels, 2022, Clinical Pharmacokinetics.